Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Cornea ; 43(8): 1040-1043, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-38488642

ABSTRACT

PURPOSE: This study addresses the growing concern of Dry Eye Disease (DED), which has become increasingly prevalent due to modern lifestyles characterized by prolonged screen usage, global warming, polypharmacy, and extended life expectancy. METHODS: Grounded in the Dry Eye Workshop II (DEWSII) diagnosis framework, the study focuses on DED as a multifactorial condition affecting the ocular surface's tear film homeostasis. The study evaluates the short-term impact of 5 commercially available ocular lubricants on disrupting the hyperosmolar environment and determine whether these lubricants can offer potential treatment benefits for DED. RESULTS: Conducted on 300 eyes (from 150 patients) with 5 preservative-free lubricants compared to a control group, the study reveals that all lubricants effectively reduced tear film osmolarity within 15 minutes of application. Notably, the control group exhibited an increase in average osmolarity (+0.98 mOsm/L) without lubricant use. Siccafluid demonstrated the most substantial osmolarity reduction after 15 minutes, with an average decrease of 11.54 mOsm/L. Statistical significance was observed for Siccafluid, Optive Fusion unique dose (UD), and Systane Ultra UD, while Hyabak and Freegen preservative free (PF) showed lower significance. CONCLUSIONS: Emphasizing the importance of disrupting the hyperosmolar environment to break the cycle of inflammation, the study concludes that ocular lubricants, at least as an immediate post-application effect, can interrupt this cycle and improve the hyperosmolar environment of the ocular surface.


Subject(s)
Dry Eye Syndromes , Lubricant Eye Drops , Tears , Humans , Osmolar Concentration , Dry Eye Syndromes/drug therapy , Dry Eye Syndromes/metabolism , Tears/chemistry , Tears/metabolism , Lubricant Eye Drops/administration & dosage , Male , Female , Middle Aged , Adult , Aged , Prospective Studies , Young Adult , Ophthalmic Solutions
2.
Rev. Soc. Colomb. Oftalmol ; 55(2): 58-62, 2022. graf, tab
Article in Spanish | LILACS, COLNAL | ID: biblio-1444887

ABSTRACT

Introducción: El pterigión es una lesión fibrovascular, hiperplásica de tejido conjuntival, que crece sobre la córnea por alteración de las células madre que participan en la regeneración del tejido. Su manejo es quirúrgico y el éxito depende del tipo de técnica utilizada. Los reportes más bajos de recurrencia y complicaciones postoperatorias se han encontrado con la técnica de autoinjerto conjuntivo-limbar. Objetivo: Establecer la recurrencia a un año en pacientes sometidos a cirugía pterigión primario con autoinjerto conjuntivo-limbar operados por residentes de oftalmología de primer año en la Clínica CES en el periodo 2015 a 2018. Diseño del estudio: Seguimiento retrospectivo a una cohorte. Método: Se realizó un muestreo probabilístico simple del 10% (110 historias clínicas) de los registros de los pacientes intervenidos entre 2015 y 2018. Resultados: El 55.7% fue mujeres, el promedio de edad fue 45 (33-61) años y se encontró una recurrencia de pterigión del 7.6% a un año. Conclusión: La recurrencia de pterigión primario intervenidos por residentes de primer año con la técnica de autoinjerto conjuntivo-limbar está dentro de lo reportado en estudios realizados con cirujanos de mayor experiencia


Background: Pterygium is a fibrovascular, hyperplastic lesion of conjunctival tissue, which grows on the cornea due to alteration of the stem cells that participate in tissue regeneration. Its management is surgical, and its success depends on the type of technique used. The lowest reports of recurrence and postoperative complications have been found with the conjunctive-limbar autograft technique. Objective: To establish the one-year recurrence in patients undergoing primary pterygium surgery with limbar-conjuntival autograft operated by first-year ophthalmology residents at the CES Clinic in the period 2015 to 2018. Study design: Follow-up to a retrospective cohort. Method: A simple probability sampling of 10% (110 medical records) was carried out of the records of the patients operated between 2015 and 2018. Results: 55.7% were women, the average age was 45 (33-61) years, and it was found a recurrence of pterygium of 7.6% at one year. Conclusion: The recurrence of primary pterygium operated by first-year residents with limbar-conjunctival autograft technique is within that reported in studies carried out with more experienced surgeons


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Conjunctival Diseases
SELECTION OF CITATIONS
SEARCH DETAIL
...